What is the treatment for conjunctival bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Conjunctival Bleeding

For subconjunctival hemorrhage, the most effective treatment is typically observation and reassurance as most cases resolve spontaneously within 1-2 weeks without intervention. 1

Types of Conjunctival Bleeding

Subconjunctival Hemorrhage

  • Presentation: Sudden, painless bright red blood under the clear conjunctiva 2
  • Common causes:
    • In younger patients: trauma and contact lens usage 1
    • In elderly: systemic vascular diseases (hypertension, diabetes, arteriosclerosis) 1
    • In children: trauma (83%) and ocular surface inflammation (13%) 3

Inflammatory Conjunctival Bleeding

  • Associated with various forms of conjunctivitis
  • May require specific treatment based on underlying cause

Treatment Algorithm

1. Subconjunctival Hemorrhage (Most Common)

  • First-line approach: Observation and reassurance
  • Patient education:
    • Explain benign nature and spontaneous resolution within 1-2 weeks
    • Avoid rubbing eyes
    • Consider artificial tears for comfort if mild irritation present

2. Bacterial Conjunctivitis with Bleeding

  • First-line treatment: 5-7 day course of broad-spectrum topical antibiotic 4
    • Moxifloxacin 0.5% ophthalmic solution three times daily for 7 days 4, 5
    • Alternative options include other fluoroquinolones or aminoglycosides

3. Viral Conjunctivitis with Bleeding

  • Treatment: Supportive care with lubricants
  • For subepithelial infiltrates: Consider topical corticosteroids at minimum effective dose if vision affected 6
  • For herpes simplex virus: Topical ganciclovir 0.15% gel three to five times per day or trifluridine 1% solution five to eight times per day 6

4. Severe Inflammatory Conditions

  • For medication-induced/preservative-induced keratoconjunctivitis:

    • Discontinue offending agent
    • Consider brief course of preservative-free topical corticosteroids for severe inflammation 6
  • For ocular mucous membrane pemphigoid:

    • Topical corticosteroids for acute inflammation
    • Systemic immunosuppressive therapy for long-term management 6

Special Considerations

When to Refer to Ophthalmology

  • Recurrent or persistent subconjunctival hemorrhage
  • Visual loss
  • Moderate to severe pain
  • Severe purulent discharge
  • Corneal involvement
  • Conjunctival scarring
  • Lack of response to therapy after 3-4 days 4

Workup for Recurrent Cases

  • Evaluate for:
    • Systemic hypertension
    • Bleeding disorders (though prevalence is <1%) 7
    • Systemic and ocular malignancies
    • Drug side effects 1

Prevention Measures

  • Frequent handwashing
  • Avoid sharing towels and pillowcases
  • Change pillowcases frequently during infection
  • Avoid touching or rubbing eyes 4
  • For contact lens wearers: appropriate lens care and frequent replacement 4

Common Pitfalls to Avoid

  • Overuse of antibiotics for viral conjunctivitis
  • Prolonged use of corticosteroids without ophthalmology supervision
  • Failure to recognize potentially serious causes of conjunctivitis
  • Inadequate hygiene education
  • Delayed referral for severe or non-responsive cases 4

References

Research

Subconjunctival hemorrhage: risk factors and potential indicators.

Clinical ophthalmology (Auckland, N.Z.), 2013

Research

Subconjunctival hemorrhage--something more you should know.

Insight (American Society of Ophthalmic Registered Nurses), 1995

Guideline

Antibiotic Treatment for Otitis Media and Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.